Compare AXSM & BLKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AXSM | BLKB |
|---|---|---|
| Founded | 2012 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 2.7B |
| IPO Year | 2015 | 2004 |
| Metric | AXSM | BLKB |
|---|---|---|
| Price | $183.18 | $63.24 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 20 | 2 |
| Target Price | ★ $176.00 | $70.50 |
| AVG Volume (30 Days) | ★ 477.8K | 334.4K |
| Earning Date | 02-17-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $561,263,000.00 | ★ $1,136,093,000.00 |
| Revenue This Year | $66.40 | N/A |
| Revenue Next Year | $56.13 | $4.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 65.83 | N/A |
| 52 Week Low | $75.56 | $54.56 |
| 52 Week High | $158.57 | $81.39 |
| Indicator | AXSM | BLKB |
|---|---|---|
| Relative Strength Index (RSI) | 79.34 | 54.22 |
| Support Level | $148.14 | $63.09 |
| Resistance Level | $158.56 | $64.64 |
| Average True Range (ATR) | 5.59 | 1.44 |
| MACD | 1.60 | 0.03 |
| Stochastic Oscillator | 96.98 | 63.47 |
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
Founded in 1981, Blackbaud provides software solutions designed to serve the "social good" community, including nonprofits, foundations, corporations, educational institutions, healthcare institutions, and individual change agents. Through M&A and organic product development efforts, the company has also moved into related areas outside core fundraising, notably into K-12 schools. The firm enables more than $100 billion in donations annually across a customer base in excess of 40,000 customers in over 100 countries.